SCHEMBL244855

SCHEMBL244855

Cc1cc2ccccc2[n+]([O-])c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.61
RAB9A P51151 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 3/20 0.37
POLB P06746 1/20 0.35
CASP6 P55212 1/20 0.35
KDM4E B2RXH2 3/20 0.35
S1PR4 O95977 1/20 0.35
MAPT P10636 1/20 0.35
S1PR1 P21453 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22326431 0.83 ATM (0.61) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL27615068 0.80 ATM (0.57) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL3084819 0.77 ATM (1.00) ATMRAB9AMEN1KMT2ANPC1
Iodide SCHEMBL4389500 0.75 PTPN1 (0.42) ATMRAB9AMEN1KMT2ANPC1
Ammonia Solution, Strong SCHEMBL17136337 0.75 ATM (0.40) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL16853932 0.75 ATM (0.40) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL12706609 0.75 ATM (0.61) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL5777213 0.74 MAPT (0.54) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL10574232 0.74 ATM (0.46) ATMRAB9AMEN1KMT2ANPC1
SCHEMBL14344280 0.71 KMT2A (0.54) ATMRAB9AMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015095430-A1 METHODS AND INTERMEDIATES FOR THE PREPARATION OF MACROLACTAMS MERCK SHARP & DOHME CORP. (US) 2015-06-25 WO disclosed
WO-2015095437-A1 METHODS AND INTERMEDIATES FOR THE PREPARATION OF MACROLACTAMS MERCK SHARP & DOHME CORP. (US) 2015-06-25 WO disclosed
CN-103209963-A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds GILEAD SCIENCES INC 2013-07-17 CN disclosed
EP-2588455-A1 2 -QUINOLINYL- ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2013-05-08 EP disclosed
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed
WO-2012003498-A1 2 -QUINOLINYL- ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-01-05 WO disclosed